Lung Cancer Clinical Trial
Official title:
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
Verified date | April 2019 |
Source | National Taipei University of Nursing and Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Aim: To develop and testing a home exercise program for lung cancer survivors to improve
their exercise tolerance and quality of life during the rehabilitation phase.
Design: An experimental design will be used in the study. The 90 lung cancer survivors, who
were diagnosed with lung cancer within one year and have completed their initial cancer
treatment, will be recruited and randomized to the control or intervention group. After
pre-test, the intervention participants will receive a 60 minutes of teaching regarding the
home rehabilitation exercise program, with a printed exercise manual. The intervention
participant will also receive a weekly phone call from the interventionist to enhance their
exercise adherence and helping to overcome exercise barriers. The similar outcome measures as
study one will be assessed on the baseline, 1th month, 3th month, and 6th month.
Measurements: The study outcomes will be evaluated by three physical measures, six-minute
walk test, Modified Borg Scale, 30-second Chair Sit-to-Stand Test, and 30-second Chair
Sit-to-Stand Test, as well as a study questionnaire including Functional Assessment of Cancer
Therapy-Lung (FACT-L) and FACIT-Fatigue. For study one the following data will be collected
from the patient'schart: post-operative pulmonary complications, days of chest tube
insertion, and days of hospitalization.
Data analysis: Descriptive analysis will be used to describe patients'demongraphics, disease
variables, and outcome variables. The Chi-square, T-test, and General Linear Mix-effect Model
will be used to test the efficacy of the study interventions.
Status | Completed |
Enrollment | 92 |
Est. completion date | March 17, 2017 |
Est. primary completion date | March 17, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: 1. aged 20 and older, 2. diagnosed with stage I-IIIB non-small cell lung cancer 3. completed initial cancer treatments and no planned cancer treatment in three months 4. Karnofsdy Performance Status equal or greater then 50 5. estimated survival time greater than six months 6. with the permission of the patient's physician Exclusion Criteria: 1. having a medical condition precluding exercise (i.e. uncontrolled arrhythmias, uncontrolled hypertension, third-degree heart block, myocardial infarction within six months, unstable angina, acute congestive heart failure and taking anticoagulation for valve diseases). 2. poor controlled diabetics (HbA1C>9%) 3. regularly exercising in moderate or higher intensity three time a week within three month 4. unable to walk independently 5. unable to communicate |
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Taipei University of Nursing and Health Sciences | Mackay Memorial Hospital, Ministry of Science and Technology, Taiwan, National Taiwan University Hospital |
Taiwan,
Benzo R, Wigle D, Novotny P, Wetzstein M, Nichols F, Shen RK, Cassivi S, Deschamps C. Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies. Lung Cancer. 2011 Dec;74(3):441-5. doi: 10.1016/j.lungcan.2011.05.011. Epub 2011 Jun 12. — View Citation
Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, Joy AA, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer. 2007 Aug 1;110(3):590-8. — View Citation
Peddle CJ, Jones LW, Eves ND, Reiman T, Sellar CM, Winton T, Courneya KS. Effects of presurgical exercise training on quality of life in patients undergoing lung resection for suspected malignancy: a pilot study. Cancer Nurs. 2009 Mar-Apr;32(2):158-65. doi: 10.1097/NCC.0b013e3181982ca1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | six-minute walk test | The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway. | Change from Baseline to 6 months | |
Secondary | 30-second arm curl test | To measure upper body strength and endurance. The participant is sitting on the edge of a stabile chair, with seat height of 44 cm (originally 43.18 cm). The back is outstretched, the feet resting flat on the ground. A handle weighing 2 kg for women or 3.5 kg for men is held in the dominant hand. The arm is directed downwards, along the chair, perpendicularly to the floor. Participant's task is, at a command given by the testing person, to rotate the hand upwards while simultaneously flexing the extremity in the elbow (flexion with supination), and subsequently to extend the extremity to its baseline position. | Change from Baseline to 6 months | |
Secondary | 30-second chair sit-to-stand test | To test leg strength and endurance. Record the number of stand a person can complete in 30 seconds. | Change from Baseline to 6 months | |
Secondary | Functional Assessment of Cancer Therapy-Lung (FACT-L) | There are two subscales, 27 items of FACT-General and 9 items of Lung Cancer Subscale. Each item is rated on a 5-point Likert scale (0-4). The total score of the 36 items represents the score of the scale. The higher values represent better quality of life. | Change from Baseline to 6 months | |
Secondary | The Functional Assessment of Chronic Illness Therapy-Fatigue | There are 13 items in the scale. Each item is rated on a 5-point Likert scale (0-4). The total score of the 13 items represents the score of the scale. The possible score for the scale ranges from 0 to 52. The higher values represent more fatigue. | Change from Baseline to 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|
||
Recruiting |
NCT05087251 -
The Transitions Project: Efficacy Trial
|
N/A |